Krispy Kreme Doughnuts - Aggressive Growth

By
A A A

Krispy Kreme Doughnuts ( KKD ) sees the Zacks Consensus Estimate move higher and gets good price appreciation with positive earnings surprises. The stock is a Zacks #1 Rank (Strong Buy).

Company Description

Krispy Kreme Doughnuts, operates as a branded retailer and wholesaler of doughnuts, complementary beverages and treats, and packaged sweets. KKD sells approximately 20 varieties of doughnuts, including various Original Glazed doughnuts, as well as coffees, espresso, cappuccino, hot chocolate, frozen drinks, juices and other beverages.

Earnings Estimates Increase

Earnings estimates for the April 2012 quarter have moved higher recently. The Zacks Consensus Estimate of $0.07 increased to $0.08 in January, an increase of 14%.

The same is true of the July 2012 quarter which indicates sustained growth in earnings. Growth in earnings is something that most aggressive growth investors search for.

Earnings Surprises Have Helped

A string of three straight earnings surprises have resulted in nice price appreciation. A big beat of $0.04 in the January 2011 quarter netted a 30% move in the stock. That beat was 44% ahead of expectations. The July 2010 quarter also saw a significant move in the stock, up 24%, after posting $0.04 in earnings when the Zacks Consensus Estimate was calling for a loss of a penny.

Be Mine

The company recently announced that it is offering "sweet one-of-a kind treats" to share with your special Valentine. Nothing says Valentine's Day like a doughnut with sprinkles on it.

Another, potentially more attractive option is to purchase a dozen doughnuts that come with a dozen Valentine cards. The real sweetness of this deal is that each card is good for one doughnut of your choice. It's the gift that keeps on giving.

Valuations

KKD trades at a premium to industry averages, with the conservative measure of price to book among the largest of premiums. 5x book value suggests that the company has very few or very valuable assets, or quite likely a combination of both. The industry average for price to book is 2.4x.

The Chart

The recent price action has shown a key move above the 200 day moving average line. Over the last 3 months, the stock has moved higher by almost 12%.

Questcor Pharmaceuticals - ticker QCOR> <P ALIGN=

Brian Bolan is an Aggressive Growth Stock Strategist for Zacks.com.

This Week's Aggressive Growth Zacks Rank Buy Stocks

Ultratech, Inc. ( UTEK ) is a Zacks #1 Rank (Strong Buy) and has consistently beat expectations. As a result, the stock performs very well following earnings.

Read Full Article.

Celestica Inc. ( CLS )has a solid outlook for 2012 and 2013 and is a Zacks #1 Rank (Strong Buy).

Read Full Article.

Teledyne Technologies ( TDY )shows a solid history of positive earnings surprise and sees expectations moving higher. These factors play a role in the stock becoming a Zacks #1 Rank (Strong Buy).

Read Full Article.

Heartland Payment Systems ( HPY ) sees earnings surprises translate into price appreciation. With estimates moving higher, this stock is a Zacks #1 Rank (Strong Buy).

Read Full Article.


 
KRISPY KREME ( KKD ): Free Stock Analysis Report
 
To read this article on Zacks.com click here.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: KKD

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

92%

Most Active by Volume

36,586,989
  • $41.35 ▼ 2.29%
33,435,019
  • $42.20 ▼ 10.86%
31,919,424
  • $9.72 ▼ 8.30%
30,045,396
  • $26.49 ▼ 1.41%
29,014,873
  • $8.05 ▼ 8%
27,308,018
  • $14.66 ▼ 8.32%
23,704,242
  • $118.93 ▼ 0.06%
23,514,654
  • $17.04 ▼ 0.41%
As of 11/28/2014, 01:06 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com